Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy

被引:7
作者
Hosaka, F [1 ]
Shiga, T [1 ]
Sakomura, Y [1 ]
Wakaumi, M [1 ]
Matsuda, N [1 ]
Kasanuki, H [1 ]
机构
[1] Tokyo Womens Med Univ, Heart Inst Japan, Dept Cardiol, Shinjuku Ku, Tokyo 1628666, Japan
关键词
amiodarone; arrhythmogenic right ventricular cardiomyopathy distribution; concentration;
D O I
10.1007/s003800200012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The tissue distribution of amiodarone and desethylamiodarone, its active metabolite, was examined in an autopsied case, an 85-year-old man, with arrhythmogenic right ventricular cardiomyopathy (ARVC) who had been receiving amiodarone for 4 years. High concentrations of amiodarone. a very highly lipophilic compound, were found in adipose and bone marrow tissues. Despite a low dose (100 mg daily), the concentrations of amiodarone were higher in the epicardial fat (570.4 mug/g) and in the right atrium (165.3 mug/g) than previously reported in patients with other cardiac diseases. The ratios of amiodarone/desethylamiodarone concentrations in both tissues were > 1. This unique distribution demonstrates the involvement of histological characteristics of ARVC, such as fatty replacement of myocardium. We anticipate that a low dose of amiodarone would be effective in preventing arrhythmia in some patients with ARVC.
引用
收藏
页码:154 / 156
页数:3
相关论文
共 46 条
  • [41] Congenital giant cardiac tumor with severe left-ventricular inflow and outflow obstruction and arrhythmia treated with pulmonary artery banding and long-term amiodarone infusion
    Takeuchi, Daiji
    Hiramatsu, Takeshi
    Nakanishi, Toshio
    ANNALS OF PEDIATRIC CARDIOLOGY, 2012, 5 (01) : 78 - 80
  • [42] Development, validation and long-term evaluation of a liquid chromatography-tandem mass spectrometry method for simultaneous quantification of amiodarone, desethylamiodarone and mexiletine in human plasma and serum
    Braakhuis, Martinus W. A.
    Pistorius, Marcel C. M.
    Postema, Pieter G.
    Hollak, Carolina E. M.
    Swart, Eleonora L.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2024, 1243
  • [43] A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation
    Channer, KS
    Birchall, A
    Steeds, RP
    Walters, SJ
    Yeo, WW
    West, JN
    Muthusamy, R
    Rhoden, WE
    Saeed, BT
    Batin, P
    Brooksby, WP
    Wilson, I
    Grant, S
    EUROPEAN HEART JOURNAL, 2004, 25 (02) : 144 - 150
  • [44] Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation
    Rivinius, Rasmus
    Helmschrott, Matthias
    Ruhparwar, Arjang
    Schmack, Bastian
    Erbel, Christian
    Gleissner, Christian A.
    Akhavanpoor, Mohammadreza
    Frankenstein, Lutz
    Darche, Fabrice F.
    Schweizer, Patrick A.
    Thomas, Dierk
    Ehlermann, Philipp
    Bruckner, Tom
    Katus, Hugo A.
    Doesch, Andreas O.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 677 - 686
  • [45] Cryptogenic organizing pneumonia due to amiodarone: long-term follow-up after corticosteroid treatmentKryptogene organisierende Pneumonie nach Amiodaron-Behandlung: Langzeitverlauf nach Corticosteroidbehandlung
    Katja Schindler
    Wolfgang Schima
    Josef F. Kaliman
    Wiener klinische Wochenschrift, 2010, 122 : 511 - 514
  • [46] Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial-a prospective multicentre study
    Erkapic, Damir
    Sperzel, Johannes
    Stiller, Sascha
    Meltendorf, Ulf
    Mermi, Johann
    Wegscheider, Karl
    Huegl, Burkhard
    EUROPEAN HEART JOURNAL, 2013, 34 (02) : 130 - 137